BROADCASTS.com

Patients with breast cancer who complied fully with their adjuvant endocrine medication lived 15 percent longer than those who skipped doses, according to a huge real-world study coordinated from T\xfcbingen University, in Baden-W\xfcrttemberg, Germany, reported at the 2023 ASCO Annual Meeting.

OncTimesTalk correspondent Peter Goodwin discusses the findings with senior author of the study, Dominik Dannehl, MD, a physician at the Department of Women's Health, T\xfcbingen University Hospital, in T\xfcbingen, Baden-W\xfcrttemberg, Germany.